Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Gastric Cancer

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 22 articles: HTML format

Single Articles

December 2023
1. TU RH, Wu SZ, Huang ZN, Zhong Q, et al
   Neurotransmitter Receptor HTR2B Regulates Lipid Metabolism to Inhibit Ferroptosis in Gastric Cancer.
   Cancer Res. 2023;83:3868-3885.
   PubMed     Abstract available
   
   
   September 2023
2. FAN Y, Song S, Li Y, Dhar SS, et al
   Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T cell Immunity in Gastric Cancer Peritoneal Metastases.
   Cancer Res. 2023 Sep 22. doi: 10.1158/0008-5472.CAN-23-0783.
   PubMed     Abstract available
   
   
   August 2023
3. YE H, Shi W, Yang J, Wang L, et al
   PICH activates Cyclin A1 transcription to drive S-phase progression and chemoresistance in gastric cancer.
   Cancer Res. 2023 Aug 30. doi: 10.1158/0008-5472.CAN-23-1331.
   PubMed     Abstract available
   
   
   May 2023
4. PETRELLI A, Rizzolio S, Pietrantonio F, Bellomo SE, et al
   BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
   Cancer Res. 2023 May 2:OF1-OF12. doi: 10.1158/0008-5472.CAN-22-2620.
   PubMed     Abstract available
   
   
   March 2023
5. NARGUND AM, Xu C, Mandoli A, Okabe A, et al
   Correction: Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.
   Cancer Res. 2023;83:804.
   PubMed    
   
   
   
6. TAURIELLO DVF
   Targeting CAFs to Improve Anti-PD-1 Checkpoint Immunotherapy.
   Cancer Res. 2023;83:655-656.
   PubMed     Abstract available
   
   
   
7. AKIYAMA T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, et al
   Stromal Reprogramming through Dual PDGFRalpha/beta Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors.
   Cancer Res. 2023;83:753-770.
   PubMed     Abstract available
   
   
   December 2022
8. SHEN Y, Zhang N, Chai J, Wang T, et al
   CircPDIA4 induces gastric cancer progression by promoting ERK1/2 activation and enhancing biogenesis of oncogenic circRNAs.
   Cancer Res. 2022 Dec 23:CAN-22-1923. doi: 10.1158/0008-5472.CAN-22-1923.
   PubMed     Abstract available
   
   
   November 2022
9. LLORCA-CARDENOSA MJ, Aronson LI, Krastev DB, Nieminuszczy J, et al
   SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance.
   Cancer Res. 2022;82:3962-3973.
   PubMed     Abstract available
   
   
   
10. O'LEARY PC, Chen H, Doruk YU, Williamson T, et al
    Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2.
    Cancer Res. 2022;82:3950-3961.
    PubMed     Abstract available
    
    
    May 2022
11. NARGUND AM, Xu C, Mandoli A, Okabe A, et al
    Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.
    Cancer Res. 2022 May 18. pii: 699013. doi: 10.1158/0008-5472.CAN-21-2072.
    PubMed     Abstract available
    
    
    
12. KUMAGAI K, Shimizu T, Takai A, Kakiuchi N, et al
    Expansion of Gastric Intestinal Metaplasia with Copy Number Aberrations Contributes to Field Cancerization.
    Cancer Res. 2022;82:1712-1723.
    PubMed     Abstract available
    
    
    March 2022
13. DUAN X, Chen H, Zhou X, Liu P, et al
    EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation.
    Cancer Res. 2022;82:1070-1083.
    PubMed     Abstract available
    
    
    
14. WANG J, Huang Q, Hu X, Zhang S, et al
    Disrupting circadian rhythm via the PER1-HK2 axis reverses trastuzumab resistance in gastric cancer.
    Cancer Res. 2022 Mar 7. pii: 682075. doi: 10.1158/0008-5472.CAN-21-1820.
    PubMed     Abstract available
    
    
    December 2021
15. JUN Y, Suh YS, Park S, Lee J, et al
    Comprehensive analysis of alternative splicing in gastric cancer identifies epithelial-mesenchymal transition subtypes associated with survival.
    Cancer Res. 2021 Dec 13. pii: 0008-5472.CAN-21-2117.
    PubMed     Abstract available
    
    
    August 2021
16. VAN DONGEN GAMS
    Improving Tumor Penetration of Antibodies and Antibody-Drug Conjugates: Taking Away the Barriers for Trojan Horses.
    Cancer Res. 2021;81:3956-3957.
    PubMed     Abstract available
    
    
    February 2021
17. AN O, Song Y, Ke X, So JB, et al
    "3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy.
    Cancer Res. 2021 Feb 8. pii: 0008-5472.CAN-20-2872.
    PubMed     Abstract available
    
    
    
18. GRUNBERG N, Pevsner-Fischer M, Goshen-Lago T, Diment J, et al
    Cancer-associated fibroblasts promote aggressive gastric cancer phenotypes via heat shock factor 1-mediated secretion of extracellular vesicles.
    Cancer Res. 2021 Feb 5. pii: 0008-5472.CAN-20-2756.
    PubMed     Abstract available
    
    
    December 2020
19. WU S, Chen M, Huang J, Zhang F, et al
    ORAI2 Promotes Gastric Cancer Tumorigenicity and Metastasis Through PI3K/Akt Signaling and MAPK-dependent Focal Adhesion Disassembly.
    Cancer Res. 2020 Dec 11. pii: 0008-5472.CAN-20-0049.
    PubMed     Abstract available
    
    
    November 2020
20. SOOTOME H, Fujita H, Ito K, Ochiiwa H, et al
    Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.
    Cancer Res. 2020;80:4986-4997.
    PubMed     Abstract available
    
    
    August 2020
21. UCHIHARA T, Miyake K, Yonemura A, Komohara Y, et al
    Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing beta1 Integrin, Enhancing Drug Resistance.
    Cancer Res. 2020;80:3222-3235.
    PubMed     Abstract available
    
    
    June 2020
22. WANG SC, Yeu Y, Hammer STG, Xiao S, et al
    Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants.
    Cancer Res. 2020;80:2114-2124.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.